Single-dose,First-in-human of KLA478
Clinical trial NCT07240675 · RECRUITING
Trial details
- NCT number
- NCT07240675
- Sponsor
- Hunan Kelun Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-26
- Primary completion
- 2026-09-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.